BROOKS Stock Overview
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹106.85 |
52 Week High | ₹185.70 |
52 Week Low | ₹57.50 |
Beta | 1.38 |
1 Month Change | 10.50% |
3 Month Change | -28.70% |
1 Year Change | 68.00% |
3 Year Change | 31.91% |
5 Year Change | 100.47% |
Change since IPO | 1,543.85% |
Recent News & Updates
Recent updates
Would Brooks Laboratories (NSE:BROOKS) Be Better Off With Less Debt?
Sep 28Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?
Jun 10Estimating The Intrinsic Value Of Brooks Laboratories Limited (NSE:BROOKS)
Feb 22Is Brooks Laboratories (NSE:BROOKS) Using Too Much Debt?
Dec 08Is Brooks Laboratories (NSE:BROOKS) A Risky Investment?
Jul 07Here's Why Brooks Laboratories (NSE:BROOKS) Can Afford Some Debt
Jan 05Brooks Laboratories (NSE:BROOKS) Is Making Moderate Use Of Debt
Sep 22Shareholder Returns
BROOKS | IN Life Sciences | IN Market | |
---|---|---|---|
7D | 6.9% | 2.7% | 2.8% |
1Y | 68.0% | 17.9% | 46.6% |
Return vs Industry: BROOKS exceeded the Indian Life Sciences industry which returned 18.5% over the past year.
Return vs Market: BROOKS exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
BROOKS volatility | |
---|---|
BROOKS Average Weekly Movement | 8.1% |
Life Sciences Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: BROOKS's share price has been volatile over the past 3 months.
Volatility Over Time: BROOKS's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 296 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
BROOKS fundamental statistics | |
---|---|
Market cap | ₹2.80b |
Earnings (TTM) | -₹142.85m |
Revenue (TTM) | ₹744.61m |
3.8x
P/S Ratio-19.6x
P/E RatioIs BROOKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BROOKS income statement (TTM) | |
---|---|
Revenue | ₹744.61m |
Cost of Revenue | ₹539.12m |
Gross Profit | ₹205.50m |
Other Expenses | ₹348.34m |
Earnings | -₹142.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -5.44 |
Gross Margin | 27.60% |
Net Profit Margin | -19.18% |
Debt/Equity Ratio | 5.3% |
How did BROOKS perform over the long term?
See historical performance and comparison